Docality.com Logo
 
Dr. Amanda  Reiter  Md image

Dr. Amanda Reiter Md

20719 E Main St
Huntingdon TN 38344
731 862-2056
Medical School: Other - Unknown
Accepts Medicare: No
Participates In eRX: No
Participates In PQRS: No
Participates In EHR: No
License #: MD25912
NPI: 1629046156
Taxonomy Codes:
207Q00000X

Request Appointment Information

Awards & Recognitions

About Us

Practice Philosophy

Conditions

Medical Malpractice Cases

None Found

Medical Board Sanctions

None Found

Referrals

None Found

Publications

Production of a dendritic cell-based vaccine containing inactivated autologous virus for therapy of patients with chronic human immunodeficiency virus type 1 infection. - Clinical and vaccine immunology : CVI
In preparation for a pilot clinical trial in patients with chronic human immunodeficiency virus type 1 (HIV-1) infection, a novel dendritic cell (DC)-based vaccine is being manufactured. The trial will test the hypothesis that isolated endogenous virus presented by DCs serves as a potent immunogen for activation of CD8(+) and CD4(+) T cells specific for a broad range of autologous HIV-1 antigens. Production of the vaccine under good manufacture practice conditions involves (i) autologous virus isolation; (ii) superinfection of CD4(+) T cells with the virus; (iii) inactivation of the virus in CD4(+) T cells, T-cell apoptosis, and coincubation of T cells with autologous DCs; and (iv) product testing and release. Endogenous virus was isolated from peripheral blood-derived CD4(+) T cells of three HIV-1-positive subjects by coincubation with autologous OKT-3-stimulated CD4(+) T cells. CD4(+) T-cell supernatants were tested for p24 levels by enzyme-linked immunosorbent assay (>25 ng/ml) and for the 50% tissue culture infective doses (TCID(50); which ranged from 4,642 to 46,416/ml on day 19 of culture). Autologous CD4(+) T cells that were separated on immunobeads (>95% purity) and superinfected with virus-expressed p24 (28 to 54%) had TCID(50) of >400/ml on days 5 to 10. Virus inactivation with psoralen (20 microg/ml) and UVB irradiation (312 nm) reduced the TCID(50) of the supernatants from 199,986 to 11/ml (>99%). 7-Amino-actinomycin D-positive, annexin V-positive CD4(+) T cells were fed to autologous DCs generated by using the Elutra cell separation system and the Aastrom system. Flow analysis showed that DC loading was complete in 24 h. On the basis of these translational results and experience with the generation of DCs from HIV-1-infected patients in a previous clinical trial, the Investigational New Drug application for clinical vaccination was submitted and approved by the FDA (application no. BB-IND-13137).

Map & Directions

20719 E Main St Huntingdon, TN 38344
View Directions In Google Maps

Nearby Doctors

12707 Lexington St
Huntingdon, TN 38344
731 864-4932
631 Rb Wilson Dr
Huntingdon, TN 38344
731 864-4461
159 Court Sq
Huntingdon, TN 38344
731 864-4400
631 Rb Wilson Dr
Huntingdon, TN 38344
731 864-4461
631 Rb Wilson Dr
Huntingdon, TN 38344
731 864-4461
159 Court Sq
Huntingdon, TN 38344
731 864-4162
631 R.B. Wilson Dr.
Huntingdon, TN 38344
731 670-0011
641 Rb Wilson Dr Suite F
Huntingdon, TN 38344
731 867-7305
25 Stone Ridge Cv
Huntingdon, TN 38344
731 869-9484